BRIGHT MINDS BIOSCIENCES INC. - Common Shares (DRUG)

CUSIP: 10919W405

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 5 signals
Share change
+373
SEC-reported price per share
$49.90
Number of holders
9
Value change
+$18,758
Number of buys
7
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,814,613

Security key

10919W405

Report period

Q3 2026

Institutions

9

Top holders

10

Ownership snapshot

Top reported holders of DRUG - BRIGHT MINDS BIOSCIENCES INC. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Ian McDonald
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
11/15
Latest evidence
30 Jun 2026
13D/G 3/4/5 13F Lead comparable stake: 14% 4 rows are not safely comparable across share classes. 13D/G row: Ian McDonald Showing 1-6 of 15 holder rows.

Quick read

Ian McDonald leads the comparable SEC ownership view at 14%.

11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Ian McDonald's linked filing trail.
Comparable ownership Top 5
Ian McDonald 14%
Janus Henderson Group Ltd. 13%
Cormorant Asset Management, LP 9.2%
Vivo Opportunity Fund Holdings, L.P. 5.2%
Vestal Point Capital, LP 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Ian McDonald
13D/G
14%
Reported 13D/G · 04 Nov 2024
$85,992,664
1,396,665 shares
$0 04 Nov 2024
Janus Henderson Group Ltd.
13D/G
JANUS HENDERSON GROUP PLC
13%
Reported 13D/G · 31 Mar 2026
$107,305,270
1,284,324 shares
+$10,721,888 31 Mar 2026
Cormorant Asset Management, LP
3/4/5 13D/G 13F
Former 10% Owner · Company
9.2%
Reported 13D/G · 30 Jun 2026
$85,025,000
950,000 shares
-$9,785,125 28 Apr 2026
Vivo Opportunity Fund Holdings, L.P.
13D/G
5.2%
Reported 13D/G · 31 Mar 2026
$42,163,090
504,645 shares
+$4,216,017 31 Mar 2026
Vestal Point Capital, LP
13D/G 13F
Company
5%
Reported 13D/G · 31 Mar 2026
$41,133,252
492,319 shares
$0 31 Mar 2026
PERCEPTIVE ADVISORS LLC
13D/G
4.6%
Reported 13D/G · 31 Dec 2025
$40,171,019
449,290 shares
+$414,952 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
9
Shares
444
Rows available
9
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
99
Q3 2026 holders
9
Holder diff
-90
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .